The food-grade cell wall anchored high efficient induction expression the fusion protein S of TGEV and PEDV in lactococcus lactis and the immunogenicity analysis

被引:0
作者
Xu, Bo [1 ]
Xiong, Weina [1 ]
Li, Yeqing [1 ]
Zhou, Tong [1 ]
Liu, Zhiwen [1 ]
Ying, Bi [1 ]
Guo, Xiaoyan [1 ]
机构
[1] Biology Science and Engineering College, Jiangxi Agricultural University, Nanchang
关键词
Cell wall anchored high efficient induction expression; Food-grade vector; Fusion protein S of TGEV and PEDV; Immunogenicity; Lactococcus lactis;
D O I
10.16429/j.1009-7848.2015.06.004
中图分类号
学科分类号
摘要
Porcine transmissible gastroenteritis and porcine epidemic diarrhea are widely spread in China, which has brought huge economic losses to Chinese breeding industry. At present, the prevention and treatments of the two diseases are still using conventional vaccine. The existing vaccine is not effective enough and there is an urgent need for a safe and efficient means of prevention. Firstly, the fusion gene S of TGEV and PEDV was successfully constructed. The pRNV48-TPs were successfully constructed by using the food-grade cell wall anchored high efficient induced expression vector pRNV48 of Lactococcus lactis. To acquire the recombinant bacteria L. lactis NZ9000/pRNV48-TPs, the recombinant plasmid was transferred into the L. lactis NZ9000 competent cells by electroporation method. Then the recombinant strain was induced by nisin and the SDS-PAGE was used to analyse the expression of the target protein after the cell wall protein was extracted. And then rabbits were administrated by injection immunization and oral immunization respectively and then analyzed by Western Blot. In order to discuss the immune response mechanism of the oral vaccine and lay a good foundation for TGEV and PEDV research and development of a safe and efficient vaccine, the Lactococcus lactis food-grade cell wall anchored high efficient induced expression vector carrier was used to induce the fusion protein S of TGEV and PEDV to produce neutralizing antibodies. ©, 2015, Chinese Institute of Food Science and Technology. All right reserved.
引用
收藏
页码:32 / 38
页数:6
相关论文
共 16 条
[1]  
HamiltonMiller J.M., The role of probiotics in the treatment and prevention of Helicobacter pylori infection, Antimicrob Agents, 22, 4, pp. 360-366, (2003)
[2]  
Koizumi S., Wakita D., Sato T., Et al., Essential role of toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84, Immunol Lett, 120, 1-2, pp. 14-19, (2008)
[3]  
Lu B., Xia W.S., Zhang G.N., Study of the in Vitro cholesterol reducing effects of Lactobacillus Plan-tarum isolated from Kefir, Dairy Sci, 32, pp. 3-5, (2004)
[4]  
Havenith C.E., Seegers J.F., Gut-associated lactobacilli for oral immunization, Food Res In, 35, 1, pp. 151-163, (2002)
[5]  
Kotzamanidis C., Kourelis A., Litopoulou-Tzanetaki E., Et al., Evaluation of adhesion capacity cell surface traits and immuno-modulatory activity of presumptive probiotic Lactobacillus strains, Int J Food Microbiol, 140, pp. 154-163, (2010)
[6]  
Diep D.B., Godager L., Brede D., Et al., Datamining and characterization of a novel pediocin-like bacteriocin system from the genome of Pediococcus ATCC 25745, Microbiol, 152, 6, pp. 1649-1659, (2006)
[7]  
Wang C., Zhang C.W., Liu H.C., Et al., Non-fusion and fusion expression of β-galactosidase from Lactobacillus bul-garicus in Lactococcus lactis, Biomed Environ Sci, 21, 5, pp. 389-397, (2008)
[8]  
Duplessis E., Theron J., Berger E., Et al., Evaluation of the Staphylococcus aureus class C nonspecific acid phosphatase (SapS) as a reporter for gene expression and protein secretion in gram-negative and gram-positive bacteria, Appl Environ Microbiol, 73, 22, pp. 7232-7239, (2007)
[9]  
Wang C., Liu H.C., Pei X.F., Et al., Construction and property study of recombinant Lactococcus lactis with non-fusion expressing of β-galactosidase, Journal of Sichuan University (Medical Science Edition), 40, 1, pp. 29-32, (2009)
[10]  
Rahaar, Varmanr, Yusoffk, Et al., Cell display system for Lactococcus lactis: a novel development for oral vaccine, Appl Microbiol Biotechnol, 6, (2005)